###begin article-title 0
###xml 79 84 <span type="species:ncbi:9606">human</span>
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
###end article-title 0
###begin p 1
###xml 606 645 606 645 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">journals.permissions@oxfordjournals.org</email>
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
###end p 1
###begin p 2
###xml 334 339 <span type="species:ncbi:9606">human</span>
###xml 475 480 <span type="species:ncbi:9606">human</span>
###xml 927 932 <span type="species:ncbi:9606">human</span>
While the ability of APOBEC3G to reduce the replication of a range of exogenous retroviruses is now well established, recent evidence has suggested that APOBEC3G can also inhibit the replication of endogenous retrotransposons that bear long terminal repeats. Here, we extend this earlier work by showing that two other members of the human APOBEC3 protein family, APOBEC3B and APOBEC3A, can reduce retrotransposition by the intracisternal A-particle (IAP) retrotransposon in human cells by 20-fold to up to 100-fold, respectively. This compares to an approximately4-fold inhibition in IAP retrotransposition induced by APOBEC3G. While both APOBEC3G and APOBEC3B specifically interact with the IAP Gag protein in co-expressing cells, and induce extensive editing of IAP reverse transcripts, APOBEC3A fails to package detectably into IAP virus-like particles and does not edit IAP reverse transcripts. These data, which identify human APOBEC3A as a highly potent inhibitor of LTR-retrotransposon function, are the first to ascribe a biological activity to APOBEC3A. Moreover, these results argue that APOBEC3A inhibits IAP retrotransposition via a novel mechanism that is distinct from, and in this case more effective than, the DNA editing mechanism characteristic of APOBEC3G and APOBEC3B.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 279 282 279 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 300 301 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 424 425 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 426 427 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 537 538 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 539 540 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 673 674 657 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 675 676 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 677 678 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 679 680 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 818 819 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 194 229 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 231 236 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 408 413 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 530 535 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 553 558 <span type="species:ncbi:9606">human</span>
###xml 666 671 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 781 810 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 812 815 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
The ability of members of the APOBEC3 protein family to confer intrinsic immunity to retroviral infection was first recognized in the case of APOBEC3G (hA3G), which can block the replication of human immunodeficiency virus type 1 (HIV-1) mutants lacking a functional copy of the vif gene (DeltaVif) (1). Subsequently, APOBEC3F (hA3F) was found to also inhibit the replication of DeltaVif, but not wild-type, HIV-1 variants (2-4). In contrast, APOBEC3B (hA3B) appears able to inhibit the replication of both wild-type and DeltaVif HIV-1 (5,6). Two other human APOBEC3 proteins, APOBEC3C (hA3C) and APOBEC3A (hA3A), at most weakly inhibit either wild-type or DeltaVif HIV-1 (2,5,7,8), although hA3C has been reported to block the replication of DeltaVif, but not wild-type, forms of simian immunodeficiency virus (SIV) (9).
###end p 4
###begin p 5
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 741 743 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 86 91 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 529 548 <span type="species:ncbi:35277">retroviral provirus</span>
###xml 714 717 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Inhibitory APOBEC3 proteins specifically interact with the nucleocapsid domain of the HIV-1 Gag protein and are packaged into progeny virions (10-16). During the subsequent infection of new target cells, the APOBEC3 proteins can interfere with reverse transcription by inducing extensive dC to dU editing of nascent proviral minus strands (15-19). This can induce degradation of the proviral intermediate, perhaps due to abortive efforts at DNA repair by cellular proteins, or can lead to fatal mutagenesis. While editing of the retroviral provirus is therefore a general characteristic of inhibitory APOBEC3 proteins, it has recently been reported that some hA3G mutants that are unable to edit can still inhibit HIV-1DeltaVif replication (20).
###end p 5
###begin p 6
###xml 181 183 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 184 186 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 226 228 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 229 231 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 264 266 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 267 269 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 545 547 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 548 550 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 788 790 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 62 65 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 176 179 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 197 218 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 220 223 <span type="species:ncbi:11786">MLV</span>
###xml 245 256 <span type="species:ncbi:11963">foamy virus</span>
###xml 258 261 <span type="species:ncbi:11963">PFV</span>
###xml 438 443 <span type="species:ncbi:4932">yeast</span>
###xml 572 578 <span type="species:ncbi:10090">murine</span>
While APOBEC3 proteins were first identified as inhibitors of HIV-1DeltaVif replication, several human APOBEC3 proteins can also inhibit other retroviruses, including not only SIV (15,21) but also murine leukemia virus (MLV) (16,19) and primate foamy virus (PFV) (22,23). Moreover, APOBEC3 proteins have also been shown to act as inhibitors of LTR-retrotransposon function. Thus, hA3G, hA3F and hA3C can inhibit Ty1 retrotransposition in yeast cells by up to 100-fold, and this inhibition correlates with C to T hypermutation of the Ty1 genome (24,25). In the case of the murine LTR-retrotransposons intracisternal A-particle (IAP) and MusD, hA3G was found to reduce retrotransposition in HeLa cells by approximately4-fold in the case of IAP and approximately10-fold in the case of MusD (26). In both cases, this inhibition again correlated with C to T hypermutation.
###end p 6
###begin p 7
###xml 397 404 397 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
In this manuscript, we have confirmed the ability of hA3G to modestly inhibit IAP retrotransposition and demonstrate that hA3B and hA3A are much more potent inhibitors, reducing productive IAP retrotransposition by up to 100-fold. Both hA3G and hA3B induce C to T hypermutation of the IAP genome and specifically interact with IAP Gag. In contrast, hA3A failed to detectably interact with IAP Gag in vivo and did not induce IAP hypermutation. These data are the first to ascribe a biological activity to hA3A and suggest that hA3A may have evolved a novel mechanism to block retrotransposon function.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
Molecular clones
###end title 9
###begin p 10
###xml 163 164 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 165 166 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 167 169 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 200 203 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 214 221 211 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3</italic>
###xml 339 341 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 403 406 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</sup>
###xml 400 406 394 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo<sup>TNF</sup></italic>
###xml 438 440 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 506 507 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 508 510 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 472 477 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We have previously described expression plasmids, based on pcDNA3, that express C-terminally HA-tagged versions of hA3A, hA3B, hA3C, hA3F, hA3G and beta-arrestin (2,6,21). Because pcDNA3 contains the neo gene, the APOBEC3 and beta-arrestin open reading frames were excised using HindIII and XhoI and cloned into the pK expression plasmid (27). The IAP retrotransposition indicator plasmid pDJ33/440N1neoTNF has been previously described (28), as has the pHIV-Luc-DeltaVif HIV-1 proviral indicator plasmid (2,21).
###end p 10
###begin title 11
Retrotransposition and toxicity assays
###end title 11
###begin p 12
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 169 172 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</sup>
###xml 166 172 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo<sup>TNF</sup></italic>
###xml 215 218 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</sup>
###xml 212 218 204 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo<sup>TNF</sup></italic>
###xml 244 247 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 254 256 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 339 340 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
HeLa cells (3 x 105) were co-transfected with 2 microg of an APOBEC3 expression plasmid, or the parental pK vector as a control, together with 2 microg of pDJ33/440N1neoTNF, pcDNA3 or a derivative of pDJ333/440N1neoTNF lacking a functional IAP pol gene (28). Forty-eight hours post-transfection, the transfected cells were harvested and 106 plated onto 10 cm dishes. A further 24 h later, the cells were subjected to selection using G418 (700 microg/ml) and maintained in G418 for a further 14 days. At this point, the cultures were either fixed and stained with crystal violet, and G418 resistant colonies counted, or the cells were used for DNA isolation using a DNAeasy kit (Qiagen). The entire IAP Gag open reading frame was then amplified by PCR and cloned into pcDNA3 prior to DNA sequencing.
###end p 12
###begin p 13
###xml 142 143 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 144 145 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 146 148 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 231 232 227 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 237 238 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 14 17 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Inhibition of HIV-1DeltaVif infectivity by different APOBEC3 proteins was assayed as previously described by co-transfection into 293T cells (2,6,21). Progeny virions were harvested 48 h after co-transfection and used to infect CD4+ CCR5+ cells. Virus encoded firefly luciferase activity was then quantitated 24 h post-infection.
###end p 13
###begin title 14
Sucrose gradient centrifugation and protein interaction assays
###end title 14
###begin p 15
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 73 76 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</sup>
###xml 70 76 66 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo<sup>TNF</sup></italic>
###xml 733 735 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 1011 1018 1007 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 630 635 <span type="species:ncbi:10090">mouse</span>
###xml 691 697 <span type="species:ncbi:9986">rabbit</span>
###xml 767 778 <span type="species:ncbi:3704">horseradish</span>
###xml 1203 1209 <span type="species:ncbi:9986">rabbit</span>
293T cells (2 x 106) were co-transfected with 20 microg of pDJ33/440N1neoTNF, or a control plasmid, together with 500 ng of pK, pK/hA3G or pK/hA3A. At 48 h post-transfection, cells were harvested into 1 ml of lysis buffer [50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% NP-40 and protease inhibitors (Roche)] and clarified by brief centrifugation. Lysates obtained from three plates were then pooled and layered onto a 9 ml 10-80% sucrose gradient. The gradients were subjected to centrifugation at 40000 r.p.m. for 2 h in an SW41 rotor. One ml fractions were collected and analyzed by western blot using either a 1:5000 dilution of a mouse anti-HA monoclonal (Covance) or a 1:2000 dilution of a rabbit anti-IAP Gag polyclonal antiserum (29). Blots were then treated with horseradish peroxidase-conjugated secondary antibodies (Amersham) and reactive proteins detected using chemiluminescence (Lumi-light, Roche). In parallel, cleared cell lysates obtained from transfected 293T cells were also used for analysis of in vivo protein binding by co-immunoprecipitation. 'Input' samples were derived directly from the cell lysates while 'bound' samples were obtained by incubating lysates in the presence of the rabbit polyclonal anti-IAP Gag antiserum and protein A Agarose (Invitrogen) for 2 h at 4degreesC. Western blots were performed as described above.
###end p 15
###begin p 16
###xml 63 71 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 176 178 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 510 516 <span type="species:ncbi:9986">rabbit</span>
The approximately73 kDa IAP Gag protein was expressed using an in vitro transcription/translation system and full-length protein isolated by elution after gel electrophoresis (29). The HA-tagged hA3A, hA3B and hA3G proteins were expressed by transfection of the relevant expression plasmids into 293T cells. At 48 h post-transfection, the cells were lysed in lysis buffer, clarified and recombinant IAP Gag protein (2 microg total) added. The lysate was then incubated at 4degreesC for 4 h, at which point the rabbit polyclonal anti-IAP Gag antiserum and protein A Agarose were added. After a further 30 min incubation at 4degreesC, the bound complexes were collected by centrifugation, washed and analyzed by western blot.
###end p 16
###begin title 17
RESULTS AND DISCUSSION
###end title 17
###begin p 18
###xml 276 279 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</sup>
###xml 273 279 273 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo<sup>TNF</sup></italic>
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 523 526 523 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 442 446 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
To examine the ability of human APOBEC3 proteins to inhibit retrotransposition of IAP in human cells, we co-transfected HeLa cells with expression plasmids encoding various APOBEC3 proteins and the previously described IAP retrotransposition indicator construct pDJ33/440N1neoTNF. This construct contains a full-length IAP genome with the neo gene inserted in the antisense orientation (28). The neo gene is expressed under the control of an SV40 promoter and is disrupted by an intron in the sense orientation. Therefore, neo expression requires transcription and splicing of the IAP transcript, followed by reverse transcription and retrotransposition into the host cell genome.
###end p 18
###begin p 19
###xml 17 25 17 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 47 56 47 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 170 175 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 178 180 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 396 405 372 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figures 1</xref>
###xml 410 412 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2A</xref>
###xml 542 550 518 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 768 771 744 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 792 801 768 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
As summarized in Figure 1, and demonstrated in Figure 2A, hA3G expression indeed reduced IAP retrotransposition by approximately4-fold, as previously reported by Esnault et al. (26). Similarly, both hA3C and hA3F reduced IAP retrotransposition by 2- to 3-fold. In contrast, hA3B reduced IAP retrotransposition by approximately20-fold while hA3A reduced IAP retrotransposition by 50- to 100-fold (Figures 1 and 2A). These differences were not due to major discrepancies in the level of expression of each APOBEC3 protein in transfected cells (Figure 1). Moreover, this inhibition did not result from non-specific toxicity, as none of the APOBEC3 proteins had any effect on the number of G418 resistant colonies obtained upon simple co-transfection of HeLa cells with a neo expression plasmid (Figure 2B).
###end p 19
###begin p 20
###xml 144 152 144 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 113 118 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 248 251 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 358 361 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 498 503 <span type="species:ncbi:9606">human</span>
###xml 554 557 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
It is interesting to compare the effect of human APOBEC3 proteins on IAP retrotransposition with their effect on HIV-1 infectivity. As shown in Figure 1, and previously reported (1-6,21), hA3G, hA3F and hA3B can potently inhibit the infectivity of HIV-1DeltaVif virions produced in their presence. In contrast, hA3C has at most a modest inhibitory effect on HIV-1DeltaVif infectivity while hA3A has no detectable phenotype. These data demonstrate that there is no correlation between the effect of human APOBEC3 proteins on IAP retrotransposition and on HIV-1DeltaVif infectivity and again argue against any non-specific toxicity induced by hA3A.
###end p 20
###begin p 21
###xml 255 264 252 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 531 538 528 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 651 658 648 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 942 951 915 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figures 1</xref>
###xml 956 958 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2A</xref>
We next used PCR to clone IAP genomic sequences from the G418 resistant colonies that arose in the HeLa cultures co-transfected with the IAP indicator plasmid and expression vectors encoding hA3A, hA3B, hA3G or beta-arrestin, which was used as a control (Figure 2A). No C to T mutations were noted upon sequencing 4320 bp of the IAP genome sequences derived from control cultures (data not shown). In contrast, we detected 79 C to T mutations after sequencing 4550 bp of IAP sequence obtained from the hA3G co-expressing cultures (Table 1) and 186 C to T changes after sequencing 5800 bp of IAP sequence obtained from the hA3B co-expressing cultures (Table 1). The approximately2-fold higher level of C to T mutations detected in the hA3B expressing cultures, when compared with the hA3G expressing cultures, may correlate with the approximately5-fold more severe inhibition of IAP retrotransposition induced by hA3B when compared with hA3G (Figures 1 and 2A).
###end p 21
###begin p 22
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 581 582 581 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 572 577 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Analysis of the sequence context of these C to T mutations showed that 73 (92%) of the 79 mutations induced by hA3G were in the sequence context CC* (where the asterisk indicates the edited residue) while the other 6 (8%) were in the sequence context TC*. In the case of hA3B, 166 (89%) of the 186 C to T mutations were in the sequence context TC*, 16 (9%) in the sequence context CC* and 2 each (1%) in the context AC* or GC*. This sequence preference for editing of IAP reverse transcripts closely mirrors the hA3G and hA3B sequence preference previously observed using HIV-1 (2,3,5,6,17,19).
###end p 22
###begin p 23
###xml 326 333 326 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 446 455 446 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figures 1</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2A</xref>
Surprisingly, sequencing of 22200 bp of IAP sequence derived from G418 resistant colonies obtained from the cultures co-transfected with the IAP retrotransposition indicator construct and the hA3A expression plasmid revealed only background levels of mutagenesis, i.e. we did not observe significant levels of C to T editing (Table 1). This result therefore strongly suggests that the potent inhibition of IAP retrotransposition induced by hA3A (Figures 1 and 2A) is not due to editing of nascent IAP reverse transcripts.
###end p 23
###begin p 24
###xml 201 206 201 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23-28</sub>
###xml 216 219 216 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2-4</sub>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 840 848 840 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 386 391 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 596 601 <span type="species:ncbi:4932">yeast</span>
The APOBEC3 protein family, as well as its more distant relatives APOBEC1, APOBEC2 and AID, contain either one or two copies of a cytidine deaminase active site, with the consensus sequence His-X-Glu-X23-28-Pro-Cys-X2-4-Cys, that also functions as a zinc coordinating region (30). Mutational disruption of either of the two active sites in hA3G can inhibit the ability of hA3G to block HIV-1 replication (16). Moreover, we have previously shown that mutation of active site residues 95-SPC-97 or 286-SPC-288 of hA3G to alanine disrupts the ability of hA3G to inhibit retrotransposition by Ty1 in yeast cells (24). We therefore introduced this same inactivating mutant into the same three active site residues in hA3A (99-SPC-101 to AAA) and asked whether this would affect the ability of hA3A to inhibit IAP retrotransposition. As shown in Figure 3, the hA3A (SPC-AAA) mutant was expressed at a level that was comparable with wild-type hA3A in transfected cells and, more importantly, fully retained its ability to block IAP retrotransposition. These data are therefore fully consistent with the hypothesis that disruption of IAP retrotransposition by hA3A occurs independently of editing.
###end p 24
###begin p 25
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 387 394 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 586 588 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 617 624 614 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 727 729 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 744 753 741 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 937 942 <span type="species:ncbi:9606">human</span>
Inhibition of retrovirus replication, and of Ty1 retrotransposition, by specific APOBEC3 proteins is mediated by their selective incorporation into retroviral or retrotransposon particles due to a specific interaction with the Gag protein (6,10-14,22,24,31). We therefore used co-immunoprecipitation to ask whether hA3A, hA3B and hA3G also specifically interact with the IAP Gag protein in vivo. In this experiment, 293T cells were co-transfected with an expression vector expressing an HA-tagged APOBEC3 or control protein (beta-arrestin), together with an IAP Gag expression plasmid (28). Proteins bound to IAP Gag in vivo were collected by immunoprecipitation at 48 h after transfection using an IAP Gag-specific antiserum (29). As shown in Figure 4A, we observed a readily detectable interaction between either hA3B or hA3G and IAP Gag. In contrast, we did not observe co-immunoprecipitation of IAP Gag with hA3A or beta-arrestin, a human cytoplasmic protein used as a negative control, in several independent experiments.
###end p 25
###begin p 26
###xml 30 39 30 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 122 129 122 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 192 200 192 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 519 528 516 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 757 765 751 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 991 999 985 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1001 1010 995 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 1107 1114 1101 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1116 1125 1110 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
While the experiment shown in Figure 4A looked at the ability of hA3A, hA3B and hA3G to interact with the IAP Gag protein in vivo, we also wished to test whether these proteins could interact in vitro. For this purpose, we prepared full-length, recombinant IAP Gag (29) and then added this purified protein to cell lysates prepared from 293T cells transfected with plasmids expressing hA3A, hA3B, hA3G or beta-arrestin. Protein complexes containing IAP Gag were then collected and analyzed by western blot. As shown in Figure 4B, we again observed a readily detectable interaction between hA3B or hA3G and IAP Gag. Remarkably, however, we also consistently observed specific binding of hA3A, but not of the beta-arrestin control protein, by IAP Gag in this in vitro assay. No binding to the protein A Sepharose matrix was observed if the recombinant IAP Gag protein was omitted from the reaction (data not shown). Therefore, it appears that hA3A, hA3B and hA3G can all interact with IAP Gag in vitro (Figure 4B) but that hA3A differs from hA3B and hA3G in being unable to form a stable complex with IAP Gag in vivo (Figure 4A).
###end p 26
###begin p 27
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 443 453 443 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vice versa</italic>
###xml 467 475 467 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 932 940 932 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 1001 1008 1001 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1061 1070 1061 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 3 8 <span type="species:ncbi:4932">yeast</span>
In yeast cells expressing hA3G, the hA3G protein migrates at its predicted, <100 kDa size on sucrose gradients in the absence of Ty1 Gag but moves to high molecular mass (HMM) fractions when Ty1 Gag is co-expressed (24). Presumably, this reflects incorporation of hA3G into Ty1 retrovirus-like particles. We therefore asked whether the migration of hA3A or hA3G on a similar sucrose gradient would be affected by co-expression of IAP Gag, and vice versa. As shown in Figure 5, all of the IAP Gag protein migrated to near the bottom of the sucrose gradient, consistent with the efficient formation of IAP retrovirus-like particles (29), and this migration was unaffected by hA3G or hA3A co-expression. Analysis of the hA3A protein showed that hA3A resided almost exclusively near the top of the sucrose gradient, well away from the HMM fractions containing the IAP Gag protein, regardless of whether IAP Gag was co-expressed or not (Figure 5). This result is consistent with our inability to detect an in vivo IAP Gag:hA3A interaction by co-immunoprecipitation (Figure 4A).
###end p 27
###begin p 28
###xml 177 185 177 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 364 372 364 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
In contrast to hA3A, hA3G was found to migrate into the HMM segment of the sucrose gradient and was, in fact, found in almost exactly the same fractions as the IAP Gag protein (Figure 5). Remarkably, the mobility of hA3G on this sucrose gradient was not affected by IAP Gag co-expression, i.e. it migrated at an HMM regardless of whether IAP Gag was co-expressed (Figure 5).
###end p 28
###begin p 29
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 497 505 497 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 560 565 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 784 789 784 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 89 94 <span type="species:ncbi:4932">yeast</span>
###xml 210 215 <span type="species:ncbi:4932">yeast</span>
###xml 265 270 <span type="species:ncbi:4932">yeast</span>
###xml 337 342 <span type="species:ncbi:4932">yeast</span>
###xml 648 653 <span type="species:ncbi:9606">human</span>
###xml 750 755 <span type="species:ncbi:9606">human</span>
It is interesting to contrast this result, obtained in 293T cells, with the situation in yeast, where hA3G migrated with an HMM in the presence of Ty1 Gag but at a low molecular mass in its absence (24). These yeast data argue that hA3G, which is clearly active in yeast cells (24,25), is only recruited into an HMM complex, at least in yeast cells, when a target Gag protein is co-expressed. Yet, in transfected 293T cells, hA3G is in an HMM complex even in the absence of IAP Gag co-expression (Figure 5). This result confirms the recent observation by Chiu et al. (32) that hA3G is found in a large, >700 kDa protein complex in actively growing human cell lines, although hA3G did migrate closer to its predicted molecular mass in resting primary human T-cells and monocytes. Chiu et al. (32) proposed, based on these data, that hA3G was incorporated into an HMM complex in dividing cells that perhaps functions to block inappropriate editing of cellular DNA by hA3G during host cell DNA synthesis.
###end p 29
###begin p 30
###xml 31 39 31 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 334 336 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 416 418 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 419 421 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 580 582 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 583 585 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 586 588 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 589 591 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 592 594 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 597 605 585 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 717 722 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 725 727 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 916 918 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 919 921 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 922 924 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 925 927 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 928 930 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 931 933 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 1215 1223 1203 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 68 73 <span type="species:ncbi:4932">yeast</span>
###xml 268 273 <span type="species:ncbi:9606">Human</span>
###xml 546 551 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 553 556 <span type="species:ncbi:11786">MLV</span>
###xml 558 561 <span type="species:ncbi:11963">PFV</span>
###xml 884 889 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 890 893 <span type="species:ncbi:103820">Gag</span>
###xml 895 898 <span type="species:ncbi:11786">MLV</span>
###xml 1021 1026 <span type="species:ncbi:9606">human</span>
Based on the data presented in Figure 5, and previously obtained in yeast cells (24), we propose that the HMM complex containing hA3G actually results from incorporation of hA3G into retrovirus-like particles derived from endogenous retroviruses and retrotransposons. Human cells contain approximately230 000 endogenous retroviruses (26) and many of these are transcriptionally active, especially in dividing cells (33-37). We know that hA3G is able to interact with a wide range of diverse retroviral and retrotransposon Gag proteins, including HIV-1, MLV, PFV, Ty1 and IAP Gag (10-14,22,24,31) (Figure 2); so it seems likely that hA3G would also interact with many endogenous retroviral Gag proteins. Of note, Chiu et al. (32) showed that the HMM complex containing hA3G is disrupted by RNase treatment. This is striking, as RNase also disrupts the ability of hA3G to interact with HIV-1 Gag, MLV Gag and Ty1 Gag (10,12,14,24,31,38). We therefore hypothesize that the HMM complex formed by hA3G in actively replicating human cells results from the formation of a heterogeneous mixture of endogenous retrovirus Gag:hA3G complexes that, in cells co-expressing hA3G and IAP Gag, also include IAP Gag:hA3G complexes (Figure 3).
###end p 30
###begin p 31
###xml 128 137 128 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figures 1</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2A</xref>
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 560 567 560 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 628 638 628 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figures 4A</xref>
###xml 643 644 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">5</xref>
###xml 824 833 824 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 913 921 913 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 1144 1152 1142 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
The most surprising result reported in this manuscript is that hA3A is an extremely potent inhibitor of IAP retrotransposition (Figures 1 and 2A). Remarkably, hA3A has not been previously observed to significantly inhibit the infectivity of any retrovirus tested (2,5,7,22,31); so this result represents the first report of a biological activity for hA3A. While hA3A is actually a more potent inhibitor of IAP retrotransposition than either hA3B or hA3G, hA3A differs from both these proteins in that it neither induced C to T hypermutation of the IAP genome (Table 1) nor detectably interacted with Gag in co-expressing cells (Figures 4A and 5). We therefore do not understand the molecular basis for this inhibition, although we do know that hA3A is not a non-specific inhibitor of HeLa transformation to G418 resistance (Figure 2B) and does not significantly affect IAP Gag expression in co-transfected cells (Figure 5). Of note, a previously described (24) inactivating mutation of the cytidine deaminase active sites in hA3G did not block the ability of hA3A to inhibit IAP retrotransposition when introduced into hA3A (99-SPC-101-->AAA) (Figure 3), a result which is fully consistent with the lack of any detectable editing of the IAP genome by wild-type hA3A.
###end p 31
###begin p 32
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 63 73 63 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figures 4A</xref>
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">5</xref>
###xml 165 173 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 175 184 175 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 881 886 881 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 1169 1171 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 1217 1219 1217 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 926 931 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1079 1096 <span type="species:ncbi:10407">Hepatitis B virus</span>
While hA3A failed to detectably interact with IAP Gag in vivo (Figures 4A and 5), we did observe a specific interaction between hA3A and recombinant IAP Gag protein in vitro (Figure 4B). This result raises the intriguing possibility that hA3A may transiently interact with IAP retrovirus-like particles either during their assembly or during the disassembly that is predicted to occur prior to the chromosomal integration of full-length IAP reverse transcripts. Unfortunately, we have not been able to quantify the level of IAP reverse transcripts in transfected cells in the absence of selection (data not shown) so we do not know whether hA3A acts before or after IAP reverse transcription. In any event, we can only hypothesize that hA3A utilizes a novel mechanism for inhibition of IAP retrotransposition that does not involve DNA editing. In this context, we note that Newman et al. (20) have proposed that inhibition of HIV-1 replication by hA3G can still be observed with certain hA3G mutants that lack a functional cytidine deaminase active site. Moreover, inhibition of Hepatitis B virus replication by hA3G may occur in the absence of significant editing (39,40), although this issue remains controversial (41). Whether this currently undefined second inhibitory mechanism is also used by hA3A to inhibit IAP retrotransposition is not currently known.
###end p 32
###begin p 33
The authors thank Thierry Heidmann for reagents used in this research. This research was funded by NIH grants AI065301 and AI057099 to B.R.C. Funding to pay the Open Access publication charges for this article was provided by NIH grant AI65301.
###end p 33
###begin p 34
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 34
###begin title 35
REFERENCES
###end title 35
###begin article-title 36
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
###end article-title 36
###begin article-title 37
###xml 7 12 <span type="species:ncbi:9606">human</span>
###xml 67 72 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 77 82 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
###end article-title 37
###begin article-title 38
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo
###end article-title 38
###begin article-title 39
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 50 85 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication
###end article-title 39
###begin article-title 40
Cytidine deamination of retroviral DNA by diverse APOBEC proteins
###end article-title 40
###begin article-title 41
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
###end article-title 41
###begin article-title 42
###xml 30 33 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G
###end article-title 42
###begin article-title 43
Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities
###end article-title 43
###begin article-title 44
###xml 47 76 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
###end article-title 44
###begin article-title 45
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor
###end article-title 45
###begin article-title 46
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein
###end article-title 46
###begin article-title 47
###xml 59 94 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes
###end article-title 47
###begin article-title 48
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The interaction between HIV-1 Gag and APOBEC3G
###end article-title 48
###begin article-title 49
###xml 28 63 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
APOBEC3G incorporation into human immunodeficiency virus type 1 particles
###end article-title 49
###begin article-title 50
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
###end article-title 50
###begin article-title 51
###xml 32 37 <span type="species:ncbi:9606">human</span>
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
###end article-title 51
###begin article-title 52
###xml 83 86 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
###end article-title 52
###begin article-title 53
###xml 72 77 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
###end article-title 53
###begin article-title 54
DNA deamination mediates innate immunity to retroviral infection
###end article-title 54
###begin article-title 55
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity
###end article-title 55
###begin article-title 56
###xml 104 107 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor
###end article-title 56
###begin article-title 57
###xml 0 11 <span type="species:ncbi:11963">Foamy virus</span>
Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors
###end article-title 57
###begin article-title 58
###xml 59 70 <span type="species:ncbi:11963">foamy virus</span>
The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein
###end article-title 58
###begin article-title 59
###xml 16 21 <span type="species:ncbi:4932">yeast</span>
###xml 45 50 <span type="species:ncbi:9606">human</span>
Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases
###end article-title 59
###begin article-title 60
###xml 73 78 <span type="species:ncbi:4932">yeast</span>
APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast
###end article-title 60
###begin article-title 61
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses
###end article-title 61
###begin article-title 62
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs
###end article-title 62
###begin article-title 63
Identification of autonomous IAP LTR retrotransposons mobile in mammalian cells
###end article-title 63
###begin article-title 64
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Nucleotide sequence of a complete mouse intracisternal A-particle genome: relationship to known aspects of particle assembly and function
###end article-title 64
###begin article-title 65
An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22
###end article-title 65
###begin article-title 66
###xml 28 49 <span type="species:ncbi:11786">murine leukemia virus</span>
Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion
###end article-title 66
###begin article-title 67
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells
###end article-title 67
###begin article-title 68
###xml 26 53 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 82 87 <span type="species:ncbi:9606">human</span>
Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray
###end article-title 68
###begin article-title 69
###xml 16 43 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 45 51 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients
###end article-title 69
###begin article-title 70
###xml 18 45 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Expression of the human endogenous retrovirus HERV-W family in various human tissues and cancer cells
###end article-title 70
###begin article-title 71
###xml 8 13 <span type="species:ncbi:9606">human</span>
Spliced human endogenous retroviral HERV-H env transcripts in T-cell leukaemia cell lines and normal leukocytes: alternative splicing pattern of HERV-H transcripts
###end article-title 71
###begin article-title 72
Assessment of retroviral activity using a universal retrovirus chip
###end article-title 72
###begin article-title 73
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 105 110 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs
###end article-title 73
###begin article-title 74
###xml 14 31 <span type="species:ncbi:10407">hepatitis B virus</span>
Inhibition of hepatitis B virus replication by APOBEC3G
###end article-title 74
###begin article-title 75
APOBEC-mediated interference with hepadnavirus production
###end article-title 75
###begin article-title 76
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 26 43 <span type="species:ncbi:10407">hepatitis B virus</span>
Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo
###end article-title 76
###begin title 77
Figures and Tables
###end title 77
###begin p 78
###xml 232 235 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</sup>
###xml 229 235 229 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo<sup>TNF</sup></italic>
###xml 585 586 577 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 592 593 584 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 384 387 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 526 531 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1022 1027 <span type="species:ncbi:10090">mouse</span>
Effect of human APOBEC3 proteins on IAP retrotransposition and HIV-1 infectivity. Upper panel: IAP retrotransposition was quantified by co-transfection of HeLa cells with the IAP retrotransposition indicator construct pDJ33/440N1neoTNF and the indicated APOBEC3 expression plasmids. After selection in G418, resistant colonies were counted. The effect of the same APOBEC3 proteins on HIV-1DeltaVif infectivity was determined by co-transfection into 293T cells together with the pHIV-Luc-DeltaVif indicator construct. Released HIV-1 virions were collected at 48 h and used to infect CD4+, CCR5+ cells. Induced, virus encoded luciferase activity was quantified 24 h later. In both cases, data are presented as a percentage of the activity seen in cultures co-transfected with a plasmid expressing the irrelevant beta-arrestin gene. Average of three independent experiments with standard deviation indicated. Lower panel: western analysis of APOBEC3 protein expression in transfected 293T cells using an anti-HA tag specific mouse monoclonal. hA3A and hA3C are predicted to be approximately22 kDa in size while hA3B, hA3F and hA3G are approximately40 kDa.
###end p 78
###begin p 79
###xml 74 75 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 169 172 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</sup>
###xml 166 172 166 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo<sup>TNF</sup></italic>
###xml 295 298 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</sup>
###xml 292 298 289 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo<sup>TNF</sup></italic>
###xml 320 323 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 520 528 517 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 531 532 528 529 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 543 544 540 541 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 618 621 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 658 661 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</sup>
###xml 655 661 652 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo<sup>TNF</sup></italic>
Effect of APOBEC3 proteins on IAP retrotransposition and cell viability. (A) HeLa cells were transfected with the IAP retrotransposition indicator plasmid pDJ33/440N1neoTNF, together with an APOBEC3 expression plasmid or a control plasmid expressing beta-arrestin. A derivative of pDJ33/440N1neoTNF lacking a functional pol gene served as the negative control. Cells were subjected to selection in G418 and resistant colonies counted 17 days after transfection. This experiment is representative of the data compiled in Figure 1. (B) Same as (A) except that HeLa cells were co-transfected with pcDNA3, which encodes a neo cDNA, instead of with pDJ33/440N1neoTNF. The negative in this case is a mock transfection.
###end p 79
###begin p 80
###xml 172 180 172 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
An hA3A mutant bearing a defective cytidine deaminase active site remains able to inhibit IAP retrotransposition. These data were derived and are presented as described in Figure 1 and again used a primary antibody specific for the HA epitope tag, present on both the beta-arrestin and hA3A proteins, in the lower panel. The hA3A (SPC-AAA) mutant bears alanine residues in place of the active site residues 99-SPC-101.
###end p 80
###begin p 81
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 146 149 146 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</sup>
###xml 143 149 143 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo<sup>TNF</sup></italic>
###xml 678 679 672 673 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 384 390 <span type="species:ncbi:9986">rabbit</span>
###xml 548 553 <span type="species:ncbi:10090">mouse</span>
###xml 886 889 <span type="species:ncbi:103820">Gag</span>
###xml 891 894 <span type="species:ncbi:103820">Gag</span>
###xml 936 942 <span type="species:ncbi:9986">rabbit</span>
Binding of IAP Gag by APOBEC3 proteins in vivo and in vitro. (A) 293T cells were co-transfected with the IAP Gag expression plasmid pDJ33/440N1neoTNF and vectors expressing HA-tagged hA3A, hA3B, hA3G or beta-arrestin, the latter as a negative control. After 48 h, the cells were lysed and an aliquot retained to analyze input protein levels. The remaining lysate was incubated with a rabbit anti-IAP Gag antiserum and protein A agarose. Bound, as well as input, proteins were separated by gel electrophoresis and visualized by western blot using a mouse monoclonal specific for the HA tag present on the APOBEC3 and beta-arrestin proteins, or using the anti-IAP Gag antiserum. (B) 293T cells were transfected with plasmids expressing HA-tagged hA3A, hA3B, hA3G or beta-arrestin and lysates prepared 2 days later. After incubation in the presence of purified full-length recombinant IAP Gag, Gag protein complexes were collected using a rabbit polyclonal anti-Gag antiserum and protein A agarose. Bound and input proteins were then visualized by western blot using an anti-HA monoclonal. For both panels, input lanes contain 2% of the starting material while bound lanes contain 25% of the immunoprecipitated protein fraction.
###end p 81
###begin p 82
###xml 111 114 111 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</sup>
###xml 108 114 108 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo<sup>TNF</sup></italic>
Sucrose gradient fractionation of IAP Gag and APOBEC3 proteins. 293T cells were transfected with pDJ33/440N1neoTNF, which expresses IAP Gag, with vectors expressing hA3G or hA3A, or with appropriate control plasmids. After 48 h, the cells were lysed and the lysates fractionated across 10-80% sucrose gradients. Fractions were then collected, with the top of the gradient at left, and subjected to western analysis using anti-IAP Gag and anti-HA tag antibodies, as indicated. M, mock transfected cell lysate; I, input cell lysate (0.5% of total).
###end p 82
###begin p 83
Relative levels of C to T editing induced in retrotransposed IAP genome sequences by co-expressed APOBEC3 proteins
###end p 83
###begin p 84
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</sup>
###xml 88 94 88 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo<sup>TNF</sup></italic>
G418 resistant colonies obtained upon co-transfection of HeLa cells with the pDJ33/440N1neoTNF IAP indicator construct, and plasmids expressing hA3A, hA3B or hA3G, were harvested and used to prepare DNA. IAP genomic sequences were then PCR amplified, cloned and sequenced. The total number of bases sequenced is shown in parentheses, with mutations indicated in the grid. Predicted bases are shown on the left and the observed bases across the top.
###end p 84

